[1]
Pinter, A., Strober, B., Rosmarin, D., Gisondi, P., Vanvoorden, V., Peterson, L., Madden, C., de Cuyper, D. and Warren, R.B. 2022. Bimekizumab in patients with moderate to severe plaque psoriasis by bodyweight: Pooled results from phase 3 trials. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s73. DOI:https://doi.org/10.25251/skin.6.supp.73.